🔗 Share this article

Chancellor Reeves has announced she is preparing "targeted measures to tackle household expense pressures" in next month's financial statement.

Speaking to media outlets, she noted that reducing inflation is a collective responsibility of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 industrialized countries this calendar year and next.

Possible Utility Bill Interventions

Sources suggest the administration could intervene to bring down energy bills, for instance by reducing the present 5% rate of value-added tax applied on energy.

An additional approach is to reduce some of the government charges currently added to bills.

Fiscal Limitations and Expert Expectations

The administration will obtain the latest assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for such measures.

The consensus from the majority of experts is that Reeves will have to declare higher taxes or budget cuts in order to meet her self-imposed borrowing rules.

Earlier on Thursday, estimates suggested there was a £22bn gap for the chancellor to address, which is at the lower end of forecasts.

"There's a joint job between the Bank of England and the administration to further reduce some of the causes of price increases," the Chancellor informed the BBC in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Commitments and International Concerns

While a great deal of the attention has been on expected tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not changed her vow to manifesto promises not to raise rates on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with increasing geopolitical and trade concerns for the Budget revenue measures, likely to be focused on those "wealthiest."

International Trade Disputes

Referring to concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security invariably come first."

Last week's declaration by Chinese authorities to tighten export controls on rare earths and other materials that are crucial for high-technology production led American leader the US President to threaten an additional 100% import tax on goods from the Asian country, increasing the risk of an full-scale trade war between the two economic giants.

The US Treasury Secretary labeled the Chinese action "economic coercion" and "a international production control attempt."

Inquired about considering the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and called on the Chinese government "not to put up barriers and limit trade."

She said the decision was "harmful for the world economy and causes further obstacles."

"In my view there are fields where we must confront Chinese policies, but there are also significant chances to sell into Chinese markets, including financial services and other sectors of the economy. We've got to get that balance right."

The chancellor also stated she was working with other major economies "on our own critical minerals plan, so that we are more independent."

NHS Drug Costs and Investment

The Chancellor also recognized that the cost the NHS spends on medicines could increase as a consequence of current negotiations with the US government and its drugs companies, in return for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or canceling investments in the UK, with several blaming the low prices they are receiving.

Recently, the Science Minister said the cost the NHS pays for drugs would need to go up to prevent businesses and pharmaceutical investment leaving the United Kingdom.

Reeves told the BBC: "It has been observed because of the cost structure, that drug testing, innovative medicines have not been available in the United Kingdom in the way that they are in other EU nations."

"We want to guarantee that individuals receiving treatment from the NHS are able to obtain the best essential drugs in the world. And so we are examining all of that, and... aiming to obtain additional funding into the UK."